keyword
https://read.qxmd.com/read/38144071/development-of-a-new-class-of-monoamine-oxidase-b-inhibitors-by-fine-tuning-the-halogens-on-the-acylhydrazones
#41
JOURNAL ARTICLE
Jayalakshmi Jayan, Jiseong Lee, Sunil Kumar, Amritha Manoharan, Anishma Payyappilliparambil Narayanan, Reenoo Jauhari, Mohamed A Abdelgawad, Mohammed M Ghoneim, Hasnaa Ali Ebrahim, Subin Mary Zachariah, Hoon Kim, Bijo Mathew
A total of 14 acyl hydrazine derivatives ( ACH1-ACH14 ) were developed and examined for their ability to block monoamine oxidase (MAO). Thirteen analogues showed stronger inhibition potency against MAO-B than MAO-A. With a half-maximum inhibitory concentration of 0.14 μM, ACH10 demonstrated the strongest inhibitory activity against MAO-B, followed by ACH14 , ACH13 , ACH8 , and ACH3 (IC50 = 0.15, 0.18, 0.20, and 0.22 μM, respectively). Structure-activity relationships suggested that the inhibition effect on MAO-B resulted from the combination of halogen substituents of the A- and/or B-rings...
December 19, 2023: ACS Omega
https://read.qxmd.com/read/38136164/a-multitarget-approach-against-neuroinflammation-alkyl-substituted-coumarins-as-inhibitors-of-enzymes-involved-in-neurodegeneration
#42
JOURNAL ARTICLE
Emanuela Berrino, Simone Carradori, Fabrizio Carta, Francesco Melfi, Marialucia Gallorini, Giulio Poli, Tiziano Tuccinardi, José G Fernández-Bolaños, Óscar López, Jacobus P Petzer, Anél Petzer, Paolo Guglielmi, Daniela Secci, Claudiu T Supuran
Neurodegenerative disorders (NDs) include a large range of diseases characterized by neural dysfunction with a multifactorial etiology. The most common NDs are Alzheimer's disease and Parkinson's disease, in which cholinergic and dopaminergic systems are impaired, respectively. Despite different brain regions being affected, oxidative stress and inflammation were found to be common triggers in the pathogenesis and progression of both diseases. By taking advantage of a multi-target approach, in this work we explored alkyl substituted coumarins as neuroprotective agents, capable to reduce oxidative stress and inflammation by inhibiting enzymes involved in neurodegeneration, among which are Carbonic Anhydrases (CAs), Monoamine Oxidases (MAOs), and Cholinesterases (ChEs)...
November 25, 2023: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/38132450/-ginkgo-biloba-antioxidant-activity-and-in-silico-central-nervous-system-potential
#43
JOURNAL ARTICLE
Eduardo Suárez-González, Jesús Sandoval-Ramírez, Jorge Flores-Hernández, Alan Carrasco-Carballo
Ginkgo biloba (GB) extracts have been used in clinical studies as an alternative therapy for Alzheimer's disease (AD), but the exact bioaction mechanism has not yet been elucidated. In this work, an in silico study on GB metabolites was carried out using SwissTargetPrediction to determine the proteins associated with AD. The resulting proteins, AChE, MAO-A, MAO-B, β-secretase and γ-secretase, were studied by molecular docking, resulting in the finding that kaempferol, quercetin, and luteolin have multitarget potential against AD...
December 1, 2023: Current Issues in Molecular Biology
https://read.qxmd.com/read/38116435/repurposing-azoles-to-resolve-serotogenic-toxicity-associated-with-linezolid-to-combat-multidrug-resistant-tuberculosis
#44
JOURNAL ARTICLE
Rukaiyya T Girase, Iqrar Ahmad, Jong Min Oh, Hoon Kim, Bijo Mathew, Siva K Vagolu, Tone Tønjum, Nisheeth C Desai, Dharmarajan Sriram, Jyothi Kumari, Harun M Patel
Serotogenic toxicity is a major hurdle associated with Linezolid in the treatment of drug-resistant tuberculosis (TB) due to the inhibition of monoamine oxidase (MAO) enzymes. Azole compounds demonstrate structural similarities to the recognized anti-TB drug Linezolid, making them intriguing candidates for repurposing. Therefore, we have repurposed azoles (Posaconazole, Itraconazole, Miconazole, and Clotrimazole) for the treatment of drug-resistant TB with the anticipation of their selectivity in sparing the MAO enzyme...
December 14, 2023: ACS Medicinal Chemistry Letters
https://read.qxmd.com/read/38095566/queuine-as-a-potential-multi-target-drug-for-alzheimer-s-disease-insights-from-protein-dynamics
#45
JOURNAL ARTICLE
Münteha Girgin, Nigar Kantarci-Carsibasi
Alzheimer's disease (AD) is a neurodegenerative disorder with a complex pathogenesis. One promising approach to treating AD is simultaneously targeting multiple aspects of the disease using a multi-target drug (MTD). In this study, multi-target drug (MTD) potential of the nutraceutical molecule Queuine was explored using molecular docking and molecular dynamics (MD) simulations with five different protein targets engaged in AD: AChE, beta-site amyloid precursor protein cleaving enzyme-1 (BACE-1), N-methyl-D-aspartate receptor (NMDAR), monoamine oxidase A (MAO-A), and Synapsin III...
December 14, 2023: Journal of Biomolecular Structure & Dynamics
https://read.qxmd.com/read/38084656/supplementing-clinical-lactation-studies-with-pbpk-modeling-to-inform-drug-therapy-in-lactating-mothers-prediction-of-primaquine-exposure-as-a-case-example
#46
JOURNAL ARTICLE
Xian Pan, Khaled Abduljalil, Lisa M Almond, Amita Pansari, Karen Rowland Yeo
Evaluating the safety of primaquine (PQ) during breastfeeding requires an understanding of its pharmacokinetics (PKs) in breast milk and its exposure in the breastfed infant. Physiologically-based PK (PBPK) modeling is primed to assess the complex interplay of factors affecting the exposure of PQ in both the mother and the nursing infant. A published PBPK model for PQ describing the metabolism by monoamine oxidase A (MAO-A; 90% contribution) and cytochrome P450 2D6 (CYP2D6; 10%) in adults was applied to predict the exposure of PQ in mothers and their breastfeeding infants...
December 12, 2023: CPT: Pharmacometrics & Systems Pharmacology
https://read.qxmd.com/read/38066695/the-intracellular-monoamine-oxidase-a-inhibitory-activity-and-the-protective-effect-of-small-hairtail-related-peptides-in-nerve-cells-sh-sy5y
#47
JOURNAL ARTICLE
Aiyuan Zhang, Xiaoxue Yang, Keying Su, Jintao Xie, Xuewu Zhang
This study was to investigate the inhibitory activity of small hairtail-related peptides (VFEVFW, LPNSLYQQ, LPNSLYQK and FADAME) on intracellular monoamine oxidase-A (MAO-A) and their protective effects in a cell model. Specifically, the inhibition activity in SH-SY5Y cells indicated that VFEVFW and LPNSLYQK reduced about 50% of MAO-A activity in cells, at 0.5 mM. The survival experiment demonstrated that the toxic effect of dexamethasone (DEX) on cells can be significantly alleviated in the presence of peptides, and these peptides can restore (>20%) the mitochondrial membrane potential of SH-SY5Y cells reduced by DEX...
December 8, 2023: Bioscience, Biotechnology, and Biochemistry
https://read.qxmd.com/read/38064100/cardioprotective-effect-of-2-ethyl-3-hydroxy-6-methylpyridinium-2-nitroxysuccinate-against-adrenaline-hydrocortisone-induced-myocardial-ischemia-in-mice-modulation-of-free-radical-processes-in-biomembranes-and-monoamine-oxidase-a-activity
#48
JOURNAL ARTICLE
Irina I Faingold, Anastasia V Smolina, Yulia V Soldatova, Darya A Poletaeva, Anastasia A Balakina, Tatyana E Sashenkova, Uguljan Yu Allayarova, Tatyana R Prikhodchenko, Svetlana V Blokhina, Lyudmila A Makartseva, David A Areshidze, Vladislav N Varfolomeev, Denis V Mishchenko, Raisa A Kotelnikova
Oxidative stress (OS) plays a key role in the development of cardiovascular diseases (CVD) in three major ways: reactive oxygen species (ROS)-induced reduction of nitric oxide (NO) bioavailability, ROS-induced inflammation and ROS-induced mitochondrial dysfunction. Oxidation of lipid molecules under the action of ROS leads to damage to membrane structures, changes the functioning of membrane-bound enzymes, and impairs membrane permeability and stability. An increase in OS results in the occurrence of endothelial dysfunction and drug tolerance, side effects, requiring discontinuation of drugs...
December 8, 2023: Cell Biochemistry and Biophysics
https://read.qxmd.com/read/38061181/synthesis-in-vitro-and-in-silico-studies-of-new-derivatives-of-diphenylpiperazine-scaffold-a-key-substructure-for-mao-inhibition
#49
JOURNAL ARTICLE
Lamiaa O El-Halaby, Walaa M El-Husseiny, Shahenda M El-Messery, Fatma E Goda
Fifteen new diphenylpiperazine hybrids were designed, synthesized and in vitro biologically evaluated against hMAOs enzymes via fluorometric method. All of our new compounds displayed strong inhibitory activities against both two isoforms of hMAOs with IC50 range of 0.091-16.32 µM. According to selectivity index values, all hybrids showed higher selectivity against hMAO-A over hMAO-B. Compound 8 exhibited the best hMAO-A inhibition activity (IC50 value = 91 nM, SI = 19.55)...
December 3, 2023: Bioorganic Chemistry
https://read.qxmd.com/read/38053684/isatin-based-benzyloxybenzene-derivatives-as-monoamine-oxidase-inhibitors-with-neuroprotective-effect-targeting-neurogenerative-disease-treatment
#50
JOURNAL ARTICLE
Feba Benny, Jong Min Oh, Sunil Kumar, Mohamed A Abdelgawad, Mohammed M Ghoneim, Mohamed Sadek Abdel-Bakky, Neelima Kukerti, Jobin Jose, Hoon Kim, Bijo Mathew
Eighteen isatin-based benzyloxybenzaldehyde derivatives from three subseries, ISB, ISFB, and ISBB, were synthesized and their ability to inhibit monoamine oxidase (MAO) was evaluated. The inhibitory activity of all synthesized compounds was found to be more profound against MAO-B than MAO-A. Compound ISB1 most potently inhibited MAO-B with an IC50 of 0.124 ± 0.007 μM, ensued by ISFB1 (IC50 = 0.135 ± 0.002 μM). Compound ISFB1 most potently inhibited MAO-A with an IC50 of 0.678 ± 0...
November 30, 2023: RSC Advances
https://read.qxmd.com/read/38049514/protective-effects-of-niacin-following-high-fat-rich-diet-an-in-vivo-and-in-silico-study
#51
JOURNAL ARTICLE
Noreen Samad, Natasha Manzoor, Ammara Batool, Aqsa Noor, Saima Khaliq, Sana Aurangzeb, Sheraz Ahmed Bhatti, Imran Imran
Niacin had long been understood as an antioxidant. There were reports that high fat diet (HFD) may cause psychological and physical impairments. The present study was aimed to experience the effect of Niacin on % growth rate, cumulative food intake, motor activity and anxiety profile, redox status, 5-HT metabolism and brain histopathology in rats. Rats were administered with Niacin at a dose of 50 mg/ml/kg body weight for 4 weeks following normal diet (ND) and HFD. Behavioral tests were performed after 4 weeks...
December 1, 2023: Scientific Reports
https://read.qxmd.com/read/38004136/antidepressant-like-effect-of-oroxylum-indicum-seed-extract-in-mice-model-of-unpredictable-chronic-mild-stress
#52
JOURNAL ARTICLE
Chorpeth Chalermwongkul, Charinya Khamphukdee, Juthamart Maneenet, Supawadee Daodee, Orawan Monthakantirat, Chantana Boonyarat, Yutthana Chotritthirong, Suresh Awale, Anake Kijjoa, Yaowared Chulikhit
Major depressive disorder (MDD) is one life-threatening disorder that is prevalent worldwide. The evident etiology of this disease is still poorly understood. Currently, herbal medicine is gaining more interest as an alternative antidepressant. Oroxylum indicum , which is used in traditional medicine and contains a potential antidepressive compound, baicalein, could have an antidepressive property. An in vitro monoamine oxidase-A (MAO-A) inhibitory assay was used to preliminarily screening for the antidepressant effect of O...
November 10, 2023: Nutrients
https://read.qxmd.com/read/37982127/molecular-imaging-of-monoamine-oxidase-a-expression-in-highly-aggressive-prostate-cancer-synthesis-and-preclinical-evaluation-of-positron-emission-tomography-tracers
#53
JOURNAL ARTICLE
Kevin Zirbesegger, Laura Reyes, Andrea Paolino, Rosina Dapueto, Florencia Arredondo, Juan P Gambini, Eduardo Savio, Williams Porcal
The role of monoamine oxidase A (MAO-A) in the aggressiveness of prostate cancer (PCa) has been established in recent years. The molecular imaging of MAO-A expression could offer a noninvasive tool for the visualization and quantification of highly aggressive PCa. This study reports the synthesis and preclinical evaluation of 11 C- and 18 F-labeled MAO-A inhibitors as positron emission tomography (PET) tracers for proof-of-concept studies in animal models of PCa. Good manufacturing practice production and quality control of these radiotracers using an automated platform was achieved...
November 10, 2023: ACS Pharmacology & Translational Science
https://read.qxmd.com/read/37959843/double-attack-to-oxidative-stress-in-neurodegenerative-disorders-mao-b-and-nrf2-as-elected-targets
#54
JOURNAL ARTICLE
Filippo Basagni, Maria Luisa Di Paolo, Giorgio Cozza, Lisa Dalla Via, Francesca Fagiani, Cristina Lanni, Michela Rosini, Anna Minarini
Oxidative stress and neuroinflammation play a pivotal role in triggering the neurodegenerative pathological cascades which characterize neurodegenerative disorders, such as Alzheimer's and Parkinson's diseases. In search for potential efficient treatments for these pathologies, that are still considered unmet medical needs, we started from the promising properties of the antidiabetic drug pioglitazone, which has been repositioned as an MAO-B inhibitor, characterized by promising neuroprotective properties. Herein, with the aim to broaden its neuroprotective profile, we tried to enrich pioglitazone with direct and indirect antioxidant properties by hanging polyphenolic and electrophilic features that are able to trigger Nrf2 pathway and the resulting cytoprotective genes' transcription, as well as serve as radical scavengers...
November 4, 2023: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/37957344/smn-deficiency-perturbs-monoamine-neurotransmitter-metabolism-in-spinal-muscular-atrophy
#55
JOURNAL ARTICLE
Valeria Valsecchi, Francesco Errico, Valentina Bassareo, Carmen Marino, Tommaso Nuzzo, Paola Brancaccio, Giusy Laudati, Antonella Casamassa, Manuela Grimaldi, Adele D'Amico, Manolo Carta, Enrico Bertini, Giuseppe Pignataro, Anna Maria D'Ursi, Alessandro Usiello
Beyond motor neuron degeneration, homozygous mutations in the survival motor neuron 1 (SMN1) gene cause multiorgan and metabolic defects in patients with spinal muscular atrophy (SMA). However, the precise biochemical features of these alterations and the age of onset in the brain and peripheral organs remain unclear. Using untargeted NMR-based metabolomics in SMA mice, we identify cerebral and hepatic abnormalities related to energy homeostasis pathways and amino acid metabolism, emerging already at postnatal day 3 (P3) in the liver...
November 13, 2023: Communications Biology
https://read.qxmd.com/read/37931668/alternate-day-fasting-ameliorated-anxiety-like-behavior-in-high-fat-diet-induced-obese-mice
#56
JOURNAL ARTICLE
Huijuan Hu, Fan Li, Shaoli Cheng, Tingting Qu, Fanqi Shen, Jie Cheng, Lina Chen, Zhenghang Zhao, Hao Hu
Alternate-day fasting (ADF) has been reported to reduce body weight, neuroinflammation and oxidative stress damage. However, it is not known whether ADF affects obesity-induced anxiety-like behavior. Here, male C57BL/6 mice were given an alternate fasting and high-fat diet (HFD) or standard chow diet (SD) every other day for 16 or 5 weeks. After the intervention, the degree of anxiety of the mice was evaluated by the open field (OF) test and the elevated plus maze (EPM) test. Pathological changes in the hippocampus, the expression of Sirt1 and its downstream protein monoamine oxidase A (MAO-A) in the hippocampus, and the expression of 5-hydroxytryptamine (5-HT) were detected...
November 4, 2023: Journal of Nutritional Biochemistry
https://read.qxmd.com/read/37921699/-in-silico-guided-in%C3%A2-vitro-study-of-traditionally-used-medicinal-plants-reveal-the-alleviation-of-post-menopausal-symptoms-through-er%C3%AE-binding-and-mao-a-inhibition
#57
JOURNAL ARTICLE
Poonam Rawat, Bhanu Kumar, Ankita Misra, Surya Pratap Singh, Sharad Srivastava
The slumping level of estrogen and serotonin in menopausal women is directly associated with the occurrence of menopausal symptoms where, estrogen receptor-β (ERβ) and monoamine oxidase-A (MAO-A) are directly involved. The present investigation aimed for validation of promising plants traditionally used to alleviate menopausal symptoms with ERβ mediated MAO-A inhibition potential through in silico disease-target network construction using Cytoscape plugins followed by molecular docking of phytomolecules through AutoDock vina...
November 3, 2023: Journal of Biomolecular Structure & Dynamics
https://read.qxmd.com/read/37916667/-n-n-dimethyltryptamine-forms-oxygenated-metabolites-via-cyp2d6-an-in-vitro-investigation
#58
JOURNAL ARTICLE
Emma Eckernäs, Alicia Macan-Schönleben, Moa Andresen-Bergström, Sofia Birgersson, Kurt-Jürgen Hoffmann, Michael Ashton
N, N -dimethyltryptamine (DMT) is a psychedelic compound that has shown potential in the treatment of depression. Aside from the primary role of monoamine oxidase A (MAO-A) in DMT metabolism, the metabolic pathways are poorly understood. Increasing this understanding is an essential aspect of ensuring safe and efficacious use of DMT.This work aimed to investigate the cytochrome 450 (CYP) mediated metabolism of DMT by incubating DMT with recombinant human CYP enzymes and human liver microsomes (HLM) followed by analysis using high-resolution mass spectrometry for metabolite identification...
November 2, 2023: Xenobiotica; the Fate of Foreign Compounds in Biological Systems
https://read.qxmd.com/read/37909464/synthesis-characterization-molecular-docking-and-molecular-dynamics-simulations-of-novel-2-5-disubstituted-1-3-4-thiadiazole-derivatives-as-potential-cholinesterase-monoamine-oxidase-dual-inhibitors-for-alzheimer-s-disease
#59
JOURNAL ARTICLE
Amal A Al-Sharabi, Asaf Evrim Evren, Begüm Nurpelin Sağlık, Leyla Yurttaş
Designing multi-targeted drugs (MTD) for Alzheimer's disease (AD) is now one of the priorities for medicinal chemists, as the disease has a complicated not fully understood pathological nature and the approved mono-targeted drugs only alleviate the symptoms. In this study, the synthesis, spectral analyses and in vitro inhibition activity against cholinesterase (ChE) and monoamine oxidase (MAO) enzymes of a novel series of N -[5-(adamantan-1-yl)-1,3,4-thiadiazol-2-yl]-2-(4-un/substituted) cyclic secondary amino-acetamide/propanamide derivatives were done...
November 1, 2023: Journal of Biomolecular Structure & Dynamics
https://read.qxmd.com/read/37895071/inhibitory-effect-of-quercetin-on-oxidative-endogen-enzymes-a-focus-on-putative-binding-modes
#60
JOURNAL ARTICLE
Stefania Olla, Chiara Siguri, Antonella Fais, Benedetta Era, Massimo Claudio Fantini, Amalia Di Petrillo
Oxidative stress is defined as an imbalance between the production of free radicals and reactive oxygen species (ROS) and the ability of the body to neutralize them by anti-oxidant defense systems. Cells can produce ROS during physiological processes, but excessive ROS can lead to non-specific and irreversible damage to biological molecules, such as DNA, lipids, and proteins. Mitochondria mainly produce endogenous ROS during both physiological and pathological conditions. Enzymes like nicotinamide adenine dinucleotide phosphate oxidase (NOX), xanthine oxidase (XO), lipoxygenase (LOX), myeloperoxidase (MPO), and monoamine oxidase (MAO) contribute to this process...
October 20, 2023: International Journal of Molecular Sciences
keyword
keyword
41398
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.